DMRA · Categories · Form 4

DMRA - SEC Form 4 insider transactions

Damora Therapeutics Inc. (DMRA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for DMRA

• 19d
  General Counsel Winslow Garrett converted options into 680 shares and sold $7,345 worth of shares (245 units at $29.98), increasing direct ownership by 23% to 2,289 units (SEC Form 4) (for withholding tax)

  4 - Damora Therapeutics, Inc. (0001800315) (Issuer)
• 116d
  SEC Form 4 filed by Jarrett Jennifer

  4 - Damora Therapeutics, Inc. (0001800315) (Issuer)
• 123d
  SEC Form 4 filed by Winslow Garrett

  4 - Damora Therapeutics, Inc. (0001800315) (Issuer)
• 123d
  SEC Form 4 filed by Turtle Cameron

  4 - Damora Therapeutics, Inc. (0001800315) (Issuer)
• 123d
  SEC Form 4 filed by Landsittel Michael

  4 - Damora Therapeutics, Inc. (0001800315) (Issuer)
• 123d
  SEC Form 4 filed by Fairmount Funds Management Llc

  4 - Damora Therapeutics, Inc. (0001800315) (Issuer)
• 123d
  SEC Form 4 filed by Cain Christopher W.

  4 - Damora Therapeutics, Inc. (0001800315) (Issuer)
• 123d
  SEC Form 4 filed by Bruno Julianne

  4 - Damora Therapeutics, Inc. (0001800315) (Issuer)

Other DMRA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends